GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Intervacc AB (OSTO:IVACC) » Definitions » YoY EPS Growth

Intervacc AB (OSTO:IVACC) YoY EPS Growth : 34.29% (As of Mar. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Intervacc AB YoY EPS Growth?

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months. Intervacc AB's YoY EPS Growth for the quarter that ended in Mar. 2024 was 34.29%.

Intervacc AB's Earnings per Share (Diluted) for the three months ended in Mar. 2024 was kr-0.23.

Intervacc AB YoY EPS Growth Historical Data

The historical data trend for Intervacc AB's YoY EPS Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Intervacc AB YoY EPS Growth Chart

Intervacc AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
YoY EPS Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only 21.10 23.99 - -172.92 -24.22

Intervacc AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
YoY EPS Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -92.31 -9.68 -168.97 43.04 34.29

Intervacc AB YoY EPS Growth Calculation

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months.

Intervacc AB's YoY EPS Growth for the fiscal year that ended in Dec. 2023 is calculated as:

YoY EPS Growth (A: Dec. 2023 )
=(Earnings per Share (Diluted) (A: Dec. 2023 )-Earnings per Share (Diluted) (A: Dec. 2022 ))/ | Earnings per Share (Diluted) (A: Dec. 2022 ) |
=(-1.59--1.28)/ | -1.28 |
=-24.22 %

Intervacc AB's YoY EPS Growth for the quarter that ended in Mar. 2024 is calculated as:

YoY EPS Growth (Q: Mar. 2024 )
=(Earnings per Share (Diluted) (Q: Mar. 2024 )-Earnings per Share (Diluted) (Q: Mar. 2023 )) / | Earnings per Share (Diluted) (Q: Mar. 2023 )) |
=(-0.23--0.35)/ | -0.35 |
=34.29 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Intervacc AB YoY EPS Growth Related Terms

Thank you for viewing the detailed overview of Intervacc AB's YoY EPS Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Intervacc AB (OSTO:IVACC) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Intervacc AB (OSTO:IVACC) » Definitions » YoY EPS Growth
Comparable Companies
OSTO:INDEX OSTO:KDEV OSTO:MVIR OSTO:NICA OSTO:INIT OSTO:IRLAB A OSTO:ITECH OSTO:SYNACT OSTO:IMMU OSTO:SANION OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
2E9:Germany
Address
Vastertorpsvagen 135, Hagersten, Stockholm, SWE, S-129 44
Website
https://www.intervacc.se
Intervacc AB is a biotechnology company. It develops new vaccines based on recombinant proteins to meet the increasing need for effective vaccines in animal health care. The company through its subsidiary focuses on diagnostics in the Swedish animal health market and offers bacteriological and mycological analyses on the Swedish market.

Intervacc AB (OSTO:IVACC) Headlines

No Headlines